Eric Loh

CEO, Trendlines Medical Singapore

Trendlines Medical Singapore CEO Eric Loh

Trendlines Medical Singapore CEO Eric Loh

Eric Loh has more than 20 years of experience in the medical device industry. Most notably, Eric played significant roles in developing Biosensors International, an early-stage cardiovascular device company, to a successful, publicly traded company on the Singapore Stock Exchange. In his role as the Managing Director of Biosensors, he oversaw the establishment of a joint venture operation in China that resulted in Biosensors’ successful entry into the fast growing Chinese markets. He also led successful sales and marketing efforts and commercialized Biosensors’ products in many other markets in Asia Pacific while managing two manufacturing facilities in Singapore.

In 2005, Eric was involved with the company’s IPO on the Singapore Stock Exchange. He continued to lead the company’s corporate development and was involved in several M&A transactions that brought value to the company’s progress.

After leaving Biosensors, Eric was the CEO of another start-up, EPI Mobile Health, where he achieved regulatory approvals of the novel mobile ECG device from the FDA, CE, and HSA that enabled the commercialization of the products in key markets in Asia.

Eric holds an M.Sc., Medical Engineering, and B.Eng. (Hons.), both from the National University of Singapore; is a graduate of an Executive MBA program affiliated with the Helsinki School of Economics; and is a CFA charterholder.